Traduction de «Rapport sur les problèmes découverts lors des essais » (Français → Anglais) :

The risk assessment concluded that there is no need for risk reduction measures beyond those which are being applied already with regard to risk to consumers, human health (physico-chemical properties), risks to the atmosphere and risks to micro-organisms in the sewage treatment plant, and that there is a need for further information and or testing with respect to risks to workers, to humans exposed via the environment and to the aquatic and terrestrial ecosystem, in order to adequately characterise the concerns regarding the persistent, bio-accumulative and toxic properties of the substance.[8] Commission Regulation 565/2006 required further studies to be carried out for the purpose of risk evaluation, including on developmental neurotoxic ...[+++]ity, human bio-monitoring and environmental monitoring programmes.[9] The risks caused by the use of Deca-BDE in EEE are aggravated by recent findings[10] about uncontrolled dumping of waste in the EU and in particular about illegal trade of WEEE to countries with sub-standard waste management conditions. User industry can apply for temporary exemptions from the ban following the criteria of Article 5(1)(b) of the present proposal.

The Test Advisory Group shall report on the results of certain SIS II tests to the SIS II Committee. The Test Advisory Group shall identify, categorise and describe any issue it detects and propose options for solutions.

On conclusion of each test phase the Commission shall draw up a report on the results, any issue it detects and options for solutions.

The risk assessment concluded that there is no need for risk reduction measures beyond those which are being applied already with regard to risk to consumers, human health (physico-chemical properties), risks to the atmosphere and risks to micro-organisms in the sewage treatment plant, and that there is a need for further information and or testing with respect to risks to workers, to humans exposed via the environment and to the aquatic and terrestrial ecosystem, in order to adequately characterise the concerns regarding the persistent, bio-accumulative and toxic properties of the substance.[8] Commission Regulation 565/2006 required further studies to be carried out for the purpose of risk evaluation, including on developmental neurotoxic ...[+++]ity, human bio-monitoring and environmental monitoring programmes.[9] The risks caused by the use of Deca-BDE in EEE are aggravated by recent findings[10] about uncontrolled dumping of waste in the EU and in particular about illegal trade of WEEE to countries with sub-standard waste management conditions. User industry can apply for temporary exemptions from the ban following the criteria of Article 5(1)(b) of the present proposal.

In terms of the approval of new drugs, specialists clearly play a critical role in catalyzing the introduction of new drugs onto the market, first by performing the appropriate discovery work in clinical trials and then as early adopters of new discoveries to enhance quality of life and health care outcomes.

(17) The Netherlands took the view that new scientific findings concerning the protection of the environment in connection with a problem that had arisen in the Netherlands after the adoption of Directive 94/60/EC justified the introduction of the notified provisions.